Literature DB >> 30776309

A comparison of human mesenchymal stem cell osteogenesis in poly(ethylene glycol) hydrogels as a function of MMP-sensitive crosslinker and crosslink density in chemically defined medium.

Aaron H Aziz1,2, Stephanie J Bryant1,2,3.   

Abstract

This study investigated osteogenesis of human mesenchymal stem cells encapsulated in matrix-metalloproteinase (MMP)-sensitive poly(ethylene glycol) (PEG) hydrogels in chemically defined medium (10 ng/ml bone morphogenic factor-2). Thiol-norbornene photoclick hydrogels were formed with CRGDS and crosslinkers of PEG dithiol (nondegradable), CVPLS-LYSGC (P1) or CRGRIGF-LRTDC (P2; dash indicates cleavage site) at two crosslink densities. Exogenous MMP-2 degraded P1 and P2 hydrogels similarly. MMP-14 degraded P1 hydrogels more rapidly than P2 hydrogels. Cell spreading was greatest in P1 low crosslinked hydrogels and to a lesser degree in P2 low crosslinked hydrogels, but not evident in nondegradable and high crosslinked MMP-sensitive hydrogels. Early osteogenesis (Alkaline phosphatase [ALP] activity) was accelerated in hydrogels that facilitated cell spreading. Contrarily, late osteogenesis (mineralization) was independent of cell spreading. Mineralized matrix was present in P1 hydrogels, but only present in P2 high crosslinked hydrogels and not yet present in nondegradable hydrogels. Overall, the low crosslinked P1 hydrogels exhibited an accelerated early and late osteogenesis with the highest ALP activity (Day 7), greatest calcium content (Day 14), and greatest collagen content (Day 28), concomitant with increased compressive modulus over time. Collectively, this study demonstrates that in chemically defined medium, hydrogel degradability is critical to accelerating early osteogenesis, but other factors are important in late osteogenesis.
© 2019 Wiley Periodicals, Inc.

Entities:  

Keywords:  extracellular matrix (ECM); hydrogel; matrix-metalloproteinase (MMP); mesenchymal stem cell (MSCs); osteogenesis

Mesh:

Substances:

Year:  2019        PMID: 30776309      PMCID: PMC6938297          DOI: 10.1002/bit.26957

Source DB:  PubMed          Journal:  Biotechnol Bioeng        ISSN: 0006-3592            Impact factor:   4.530


  43 in total

1.  Alpha(1)-proteinase inhibitor, alpha(1)-antichymotrypsin, or alpha(2)-macroglobulin is required for vascular smooth muscle cell spreading in three-dimensional fibrin gel.

Authors:  Y Ikari; K Fujikawa; K O Yee; S M Schwartz
Journal:  J Biol Chem       Date:  2000-04-28       Impact factor: 5.157

2.  Loss of MMP-2 disrupts skeletal and craniofacial development and results in decreased bone mineralization, joint erosion and defects in osteoblast and osteoclast growth.

Authors:  Rebecca A Mosig; Oonagh Dowling; Analisa DiFeo; Maria Celeste M Ramirez; Ian C Parker; Etsuko Abe; Janane Diouri; Aida Al Aqeel; James D Wylie; Samantha A Oblander; Joseph Madri; Paolo Bianco; Suneel S Apte; Mone Zaidi; Stephen B Doty; Robert J Majeska; Mitchell B Schaffler; John A Martignetti
Journal:  Hum Mol Genet       Date:  2007-03-30       Impact factor: 6.150

3.  Characterization of cells with osteogenic potential from human marrow.

Authors:  S E Haynesworth; J Goshima; V M Goldberg; A I Caplan
Journal:  Bone       Date:  1992       Impact factor: 4.398

Review 4.  MT1-MMP: a key regulator of cell migration in tissue.

Authors:  Yoshifumi Itoh
Journal:  IUBMB Life       Date:  2006-10       Impact factor: 3.885

5.  Regulation of bone matrix protein expression and induction of differentiation of human osteoblasts and human bone marrow stromal cells by bone morphogenetic protein-2.

Authors:  F Lecanda; L V Avioli; S L Cheng
Journal:  J Cell Biochem       Date:  1997-12-01       Impact factor: 4.429

6.  Matrix stiffness regulation of integrin-mediated mechanotransduction during osteogenic differentiation of human mesenchymal stem cells.

Authors:  Yu-Ru V Shih; Kuo-Fung Tseng; Hsiu-Yu Lai; Chi-Hung Lin; Oscar K Lee
Journal:  J Bone Miner Res       Date:  2011-04       Impact factor: 6.741

Review 7.  Regulating expression of the gene for matrix metalloproteinase-1 (collagenase): mechanisms that control enzyme activity, transcription, and mRNA stability.

Authors:  M P Vincenti; L A White; D J Schroen; U Benbow; C E Brinckerhoff
Journal:  Crit Rev Eukaryot Gene Expr       Date:  1996       Impact factor: 1.807

8.  MT1-MMP controls human mesenchymal stem cell trafficking and differentiation.

Authors:  Changlian Lu; Xiao-Yan Li; Yuexian Hu; R Grant Rowe; Stephen J Weiss
Journal:  Blood       Date:  2009-11-09       Impact factor: 22.113

9.  Relationship between in vitro growth promotion and biophysical and biochemical properties of the serum supplement.

Authors:  P J Price; E A Gregory
Journal:  In Vitro       Date:  1982-06

Review 10.  Programmable Hydrogels for Cell Encapsulation and Neo-Tissue Growth to Enable Personalized Tissue Engineering.

Authors:  Stephanie J Bryant; Franck J Vernerey
Journal:  Adv Healthc Mater       Date:  2017-10-04       Impact factor: 9.933

View more
  4 in total

1.  IDG-SW3 Osteocyte Differentiation and Bone Extracellular Matrix Deposition Are Enhanced in a 3D Matrix Metalloproteinase-Sensitive Hydrogel.

Authors:  Aaron H Aziz; Rachel L Wilmoth; Virginia L Ferguson; Stephanie J Bryant
Journal:  ACS Appl Bio Mater       Date:  2020-02-19

2.  A 3D, Dynamically Loaded Hydrogel Model of the Osteochondral Unit to Study Osteocyte Mechanobiology.

Authors:  Rachel L Wilmoth; Virginia L Ferguson; Stephanie J Bryant
Journal:  Adv Healthc Mater       Date:  2020-10-19       Impact factor: 9.933

Review 3.  Tumor Microenvironment and Hydrogel-Based 3D Cancer Models for In Vitro Testing Immunotherapies.

Authors:  Chiara Vitale; Monica Marzagalli; Silvia Scaglione; Alessandra Dondero; Cristina Bottino; Roberta Castriconi
Journal:  Cancers (Basel)       Date:  2022-02-17       Impact factor: 6.639

4.  A combined cell and growth factor delivery for the repair of a critical size tibia defect using biodegradable hydrogel implants.

Authors:  Talia Cohen; Olga Kossover; Eli Peled; Tova Bick; Lena Hasanov; Tan Tuan Chun; Simon Cool; Dina Lewinson; Dror Seliktar
Journal:  J Tissue Eng Regen Med       Date:  2022-02-04       Impact factor: 4.323

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.